To exclude the compounding effects of amyloid-β (Aβ), it is critical to investigate the impact of APOE alleles in primary tauopathies such as PSP and CBD, which share clinical and pathological mechanisms of tau dysfunction9, or use pure tau transgenic mouse model system. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.